Current Context : India’s first indigenous antibiotic launched by the Ministry of Science & Technology to combat Antimicrobial Resistance (AMR).
About Nafithromycin
Created with support from BIRAC under its Biotechnology Industry Partnership Program (BIPP).
Market Name: Commercially introduced as “Miqnaf” by Wolkardt Pharma.
Purpose:
Advantages:
About Antimicrobial Resistance (AMR).
This reduces or nullifies the effectiveness of treatments, making infections harder to treat and increasing the risk of disease spread, severe illness, and death.
© 2025 Civilstap Himachal Design & Development